Gore Range Capital
Finance · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
767 3rd Ave Rm 7FL, New York, New York, ...Phone Number
(714) 291-6700Website
www.gorerangecapital.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Gore Range Capital
Gore Range Capital is a venture capital firm specializing in early-stage healthcare investments, focusing on science-led platforms in precision health, regenerative medicine, and personalized therapeutics. Founded in 2015, the firm combines private equity operational discipline with venture investing's scientific partnership model, providing strategic and clinical guidance to accelerate innovation and commercialization. The firm targets innovative companies that address aging and chronic disease through scalable healthcare solutions. By leveraging deep domain expertise and global clinical networks, Gore Range Capital aims to enhance quality of life and extend healthspan through its investments.Explore more
Gore Range Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gore Range Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Gore Range Capital has new funding data
Check out if Gore Range Capital is spiking on competitors!
Gore Range Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Gore Range Capital had a recent Job posting/layoffs
Product Launch: Get notified when Gore Range Capital launches new products
Congratulate Masked Content for being promoted to Masked Content at Gore Range Capital
Check if Gore Range Capital has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Gore Range Capital recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Gore Range Capital
Compare insights from companies similar to Gore Range Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gore Range Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Gore Range Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Gore Range Capital.
Gore Range Capital Tech Stack
A closer look at the technologies used by Gore Range Capital
Gore Range Capital News & Media
Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market
SOUTHLAKE, Texas, Jan. 8, 2024 /PRNewswire/ -- Novaestiq Corp., a growth-oriented aesthetic and medical dermatological innovations company, focused on delivering a platform of creative solutions to practices and patients, proudly announces its definitive agreement with Croma-Pharma GmbH...AOA Dx Raises $17M in Funding
AOA Dx, a NYC-based company developing a detection test for ovarian cancer, raised $17M in funding. The round was led by Good Growth Capital with participation from RH Capital, Y Combinator, Astia Fund, Adaptive Capital Partners, Gore Range Capital, LongeVC, The Helm, VU Venture Partners, and FemHealth Ventures with diagnostic investors, including Labcorp Venture Fund. […] The post AOA Dx Raises $17M in Funding appeared first on FinSMEs.Palvella Therapeutics Announces Series D Financing of Up to $37.7 Million to Accelerate Late-Stage Development and Support Commercialization of Novel Therapies for Serious, Rare Genetic Skin Diseases
Led by new investor Petrichor, with participation from new and existing investors Lead product candidate, QTORIN™ rapamycin, in late-stage clinical development for serious, rare genetic skin diseases with no FDA-approved therapies Top-line data expected in mid-2023 from Phase 3 pivotal study evaluating QTORIN™ rapamycin in Pachyonychia Congenita WAYNE, Pa., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a late clinical-stage biopharmaceutical company whose vision is to become theDavid Hashemi, MD, MBA Joins Gore Range Capital as Entrepreneur-in-Residence
David A. Hashemi, MD, MBA, a senior dermatology resident physician at Harvard Medical School, has joined Gore Range Capital as Entrepreneur-In-Residence.... Read More The post David Hashemi, MD, MBA Joins Gore Range Capital as Entrepreneur-in-Residence appeared first on citybiz.
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gore Range Capital
Sign Up For FreeTo access detailed company insights
Gore Range Capital is a venture capital firm specializing in early-stage healthcare investments, focusing on science-led platforms in precision health, regenerative medicine, and personalized therapeutics. Founded in 2015, the firm combines private equity operational discipline with venture investing's scientific partnership model, providing strate... Read More
